These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25575864)

  • 1. Delivery of bortezomib with nanoparticles for basal-like triple-negative breast cancer therapy.
    Shen S; Du XJ; Liu J; Sun R; Zhu YH; Wang J
    J Control Release; 2015 Jun; 208():14-24. PubMed ID: 25575864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.
    Liu Y; Zhu YH; Mao CQ; Dou S; Shen S; Tan ZB; Wang J
    J Control Release; 2014 Oct; 192():114-21. PubMed ID: 25016158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds.
    Sun TM; Wang YC; Wang F; Du JZ; Mao CQ; Sun CY; Tang RZ; Liu Y; Zhu J; Zhu YH; Yang XZ; Wang J
    Biomaterials; 2014 Jan; 35(2):836-45. PubMed ID: 24144908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer.
    Yuan H; Guo H; Luan X; He M; Li F; Burnett J; Truchan N; Sun D
    Mol Pharm; 2020 Jul; 17(7):2275-2286. PubMed ID: 32485107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Triple-punch" strategy for triple negative breast cancer therapy with minimized drug dosage and improved antitumor efficacy.
    Su S; Tian Y; Li Y; Ding Y; Ji T; Wu M; Wu Y; Nie G
    ACS Nano; 2015 Feb; 9(2):1367-78. PubMed ID: 25611071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
    Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
    Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
    Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
    J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiphilic micelles of poly(2-methyl-2-carboxytrimethylene carbonate-co-D,L-lactide)-graft-poly(ethylene glycol) for anti-cancer drug delivery to solid tumours.
    Ho KS; Aman AM; Al-awar RS; Shoichet MS
    Biomaterials; 2012 Mar; 33(7):2223-9. PubMed ID: 22182751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle.
    Zhou Z; Kennell C; Jafari M; Lee JY; Ruiz-Torres SJ; Waltz SE; Lee JH
    Int J Pharm; 2017 Sep; 530(1-2):300-307. PubMed ID: 28778627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.
    Gu Z; Wang X; Cheng R; Cheng L; Zhong Z
    Acta Biomater; 2018 Oct; 80():288-295. PubMed ID: 30240956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy.
    Devulapally R; Lee T; Barghava-Shah A; Sekar TV; Foygel K; Bachawal SV; Willmann JK; Paulmurugan R
    Nanomedicine (Lond); 2018 May; 13(9):1051-1066. PubMed ID: 29790803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycine-Poly-L-Lactic Acid Copolymeric Nanoparticles for the Efficient Delivery of Bortezomib.
    Rajoria S; Rani S; Chaudhari D; Jain S; Gupta U
    Pharm Res; 2019 Sep; 36(11):160. PubMed ID: 31520196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer.
    Yang A; Qin S; Schulte BA; Ethier SP; Tew KD; Wang GY
    Cancer Res; 2017 Dec; 77(23):6641-6650. PubMed ID: 28951456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression.
    Liu R; Shi P; Nie Z; Liang H; Zhou Z; Chen W; Chen H; Dong C; Yang R; Liu S; Chen C
    Theranostics; 2016; 6(4):533-44. PubMed ID: 26941846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
    Li Y; Xiao Y; Lin HP; Reichel D; Bae Y; Lee EY; Jiang Y; Huang X; Yang C; Wang Z
    Biomaterials; 2019 Jan; 188():160-172. PubMed ID: 30352320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of functionalized gold nanoparticles for drug delivery in cancer therapy: a NMR based approach.
    Coelho SC; Rangel M; Pereira MC; Coelho MA; Ivanova G
    Phys Chem Chem Phys; 2015 Jul; 17(29):18971-9. PubMed ID: 26126833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.